Zhu Z, Yuan L, Wang J, Li Q, Yang C, Gao X, Chen S, Han S, Liu J, Wu H, Yue S, Shi J, Cheng R, Cheng X, Han T, Jiang H, Bao L, Chen C. Mortality and morbidity of infants born extremely Preterm at Tertiary Medical Centers in China from 2010 to 2019. Jama Netw Open. 2021;4:e219382.

Article  PubMed  PubMed Central  Google Scholar 

Cao Y, Jiang S, Sun J, Hei M, Wang L, Zhang H, Ma X, Wu H, Li X, Sun H, Zhou W, Shi Y, Wang Y, Gu X, Yang T, Lu Y, Du L, Chen C, Lee SK, Zhou W. Assessment of neonatal Intensive Care Unit practices, Morbidity, and Mortality among very Preterm infants in China. Jama Netw Open. 2021;4:e2118904.

Article  PubMed  PubMed Central  Google Scholar 

Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, Walsh MC, Vohr BR, Stoll BJ, Carlo WA, Van Meurs KP, Rysavy MA, Patel RM, Merhar SL, Sánchez PJ, Laptook AR, Hibbs AM, Cot-ten CM, D’Angio CT, Winter S, Fuller J, Das A, Mortality. In-Hospital morbidity, Care practices, and 2-Year outcomes for extremely Preterm infants in the US, 2013–2018. Jama-J Am Med Assoc. 2022;327:248–63.

Article  Google Scholar 

Jeon GW, Oh M, Chang YS. Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely pre-term infants in Korean neonatal network. Sci Rep. 2021;11:24349.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeon GW, Oh M, Lee J, Jun YH, Chang YS. Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants. Sci Rep. 2022;12:18095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katz TA, Vliegenthart R, Aarnoudse-Moens C, Leemhuis AG, Beuger S, Blok GJ, van Brakel M, van den Heuvel M, van Kempen A, Lutterman C, Rijpert M, Schiering IA, Ran NC, Visser F, Wilms J, van Kaam AH, Onland W. Severity of Bronchopulmonary Dysplasia and Neurodevelopmental Outcome at 2 and 5years Cor-rected age. J Pediatr. 2022;243:40–6.

Article  PubMed  Google Scholar 

Katz TA, van Kaam AH, Schuit E, Mugie SM, Aarnoudse-Moens C, Weber EH, de Groof F, van Laerhoven H, Counsilman CE, van der Schoor S, Rijpert M, Schiering IA, Wilms J, Leemhuis AG, Onland W. Compari-son of New Bronchopulmonary Dysplasia definitions on Long-Term outcomes in Preterm infants. J Pediatr. 2023;253:86–93.

Article  PubMed  Google Scholar 

Jensen EA, Edwards EM, Greenberg LT, Soll RF, Ehret D, Horbar JD. Severity of Bronchopulmonary Dysplasia among very Preterm infants in the United States. Pediatrics. 2021;148(1):e2020030007.

Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia. Bmj-British Medi-cal J. 2021;375:n1974.

Google Scholar 

Hwang JS, Rehan VK. Recent advances in Bronchopulmonary Dysplasia: pathophysiology, Prevention, and treat-ment. Lung. 2018;196:129–38.

Article  PubMed  PubMed Central  Google Scholar 

Shukla VV, Ambalavanan N. Recent advances in Bronchopulmonary Dysplasia. Indian J Pediatr. 2021;88:690–5.

Article  PubMed  Google Scholar 

Chen YT, Lan HY, Tsai YL, Wu HP, Liaw JJ, Chang YC. Effects of bradycardia, hypoxemia and early intuba-tion on bronchopulmonary dysplasia in very preterm infants: an observational study. Heart Lung. 2024;65:109–15.

Article  PubMed  Google Scholar 

Uberos J, Jimenez-Montilla S, Molina-Oya M, García-Serrano JL. Early energy restriction in premature infants and bronchopulmonary dysplasia: a cohort study. Br J Nutr. 2020;123:1024–31.

Article  CAS  PubMed  Google Scholar 

Piersigilli F, Van Grambezen B, Hocq C, Danhaive O. Nutrients and Microbiota in Lung diseases of Prematurity: the placenta-gut-lung triangle. Nutrients. 2020;12(2):469.

Yumani D, Calor AK, van Weissenbruch MM. The course of IGF-1 levels and nutrient intake in extremely and very Preterm infants during Hospitalisation. Nutrients. 2020;12(3):675.

Kuiper-Makris C, Selle J, Nüsken E, Dötsch J, Alejandre AM. Perinatal Nutritional and metabolic pathways: early origins of Chronic Lung diseases. Front Med. 2021;8:667315.

Article  Google Scholar 

Sun T, Yu H, Li D, Zhang H, Fu J. Emerging role of metabolic reprogramming in hyperoxia-associated neonatal diseases. Redox Biol. 2023;66:102865.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonadies L, Moschino L, Valerio E, Giordano G, Manzoni P, Baraldi E. Early biomarkers of Bronchopulmonary Dysplasia: a quick look to the state of the art. Am J Perinatol. 2022;39:S26–30.

Article  PubMed  Google Scholar 

Hocq C, Vanhoutte L, Guilloteau A, Massolo AC, Van Grambezen B, Carkeek K, Piersigilli F, Danhaive O. Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia. Pediatr Res. 2022;91:804–15.

Article  PubMed  Google Scholar 

Piersigilli F, Bhandari V. Metabolomics of bronchopulmonary dysplasia. Clin Chim Acta. 2020;500:109–14.

Article  CAS  PubMed  Google Scholar 

Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137:293–300.

Article  CAS  PubMed  Google Scholar 

Noto A, Fanos V, Dessì A. Metabolomics in newborns. Advan Clin Chem. 2016;74:35–61.

Article  CAS  Google Scholar 

Fanos V, Pintus R, Dessì A. Clinical metabolomics in Neonatology: from metabolites to diseases. Neonatology. 2018;113:406–13.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj-British Med J. 2021;372:n71.

Article  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Bmc Med Res Methodol. 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805.

Article  PubMed  Google Scholar 

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

Article  PubMed  Google Scholar 

Rüdiger M, von Baehr A, Haupt R, Wauer RR, Rüstow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit Care Med. 2000;28:1572–7.

Article  PubMed  Google Scholar 

Fanos V, Pintus MC, Lussu M, Atzori L, Noto A, Stronati M, Guimaraes H, Marcialis MA, Rocha G, Moretti C, Papoff P, Lacerenza S, Puddu S, Giuffrè M, Serraino F, Mussap M, Corsello G. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease. J Matern-Fetal Neo-natal Med. 2014;27(Suppl 2):39–45.

Article  CAS  Google Scholar 

Baraldi E, Giordano G, Stocchero M, Moschino L, Zaramella P, Tran MR, Carraro S, Romero R, Gervasi MT. Untargeted Metabolomic Analysis of Amniotic Fluid in the prediction of Preterm Delivery and Bronchopulmonary Dysplasia. PLoS ONE. 2016;11:e0164211.

Article  PubMed  PubMed Central  Google Scholar 

Pintus MC, Lussu M, Dessì A, Pintus R, Noto A, Masile V, Marcialis MA, Puddu M, Fanos V, Atzori L. Urinary (1)H-NMR Metabolomics in the First Week of Life Can Anticipate BPD Diagnosis. Oxidative Med. Cell. Lon-gev. 2018, 2018, 7620671.

La Frano MR, Fahrmann JF, Grapov D, Pedersen TL, Newman JW, Fiehn O, Underwood MA, Mestan K, Steinhorn RH, Wedgwood S. Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension. Am J Physiol -Lung Cell Mol Physiol. 2018;315:L870–81.

Article  PubMed  PubMed Central  Google Scholar 

Peilian H, Sitao L, Hu H, Fei M, Xin X. Differential analysis of urinary metabolites in premature infants with bronchopulmonary dysplasia within 36 hours after birth. Chin J Neonatology (Chinese English). 2019;34:423–8.

Google Scholar 

Sitao L, Hao H, Mengxian Liu. Peilian Huang; Gu Xia; Qiuping Yang; Xin Xiao. Analysis of blood metabolites in pre-term infants with bronchopulmonary dysplasia using liquid chromatography-tandem mass spectrometry. Chin J Perinat Med. 2019;22:173–9.

Google Scholar 

Piersigilli F, Lam TT, Vernocchi P, Quagliariello A, Putignani L, Aghai ZH, Bhandari V. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics. Metabolomics. 2019;15:20.

Article  CAS  PubMed  Google Scholar 

Frazer LC, Yakah W, Martin CR. Decreased Acetic Acid in the Stool of Preterm infants is Associated with an In-creased risk of Bronchopulmonary Dysplasia. Nutrients. 2022;14(12):2412.

Wang L, Zhong WH, Liu DY, Shen HQ, He ZJ. Metabolic analysis of infants with bronchopulmonary dysplasia under early nutrition therapy: an observational cohort study. Exp Biol Med. 2022;247:470–9.

Article  CAS